Chuck Royce's KEQU Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 49,700 shares of Kewaunee Scientific Corporation (KEQU) worth $1.77 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Chuck Royce has maintained this position in KEQU for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 7,010 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Kewaunee Scientific Corporation (KEQU) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kewaunee Scientific Corporation (KEQU) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1,700 | Add 3.54% | 49,700 | $35.52 |
| Q1 2026 | +2,000 | Add 4.35% | 48,000 | $34.27 |
| Q4 2025 | +7,010 | Add 17.98% | 46,000 | $37.41 |
| Q3 2025 | +38,990 | New Buy | 38,990 | $42.65 |
Chuck Royce's Kewaunee Scientific Corporation Investment FAQs
Chuck Royce first purchased Kewaunee Scientific Corporation (KEQU) in Q3 2025, acquiring 38,990 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Kewaunee Scientific Corporation (KEQU) for 4 quarters since Q3 2025.
Chuck Royce's largest addition to Kewaunee Scientific Corporation (KEQU) was in Q3 2025, adding 38,990 shares worth $1.66 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 49,700 shares of Kewaunee Scientific Corporation (KEQU), valued at approximately $1.77 M.
As of the Q2 2026 filing, Kewaunee Scientific Corporation (KEQU) represents approximately 0.01% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Kewaunee Scientific Corporation (KEQU) was 49,700 shares, as reported at the end of Q2 2026.